With regard to the government's decision to terminate the development of an HIV vaccine manufacturing facility: (a) on what date was the Public Health Agency of Canada first informed that the Gates Foundation had commissioned a report to analyze the current vaccine manufacturing capacity in North America and Europe; (b) on what date was the Public Health Agency of Canada first informed of the results of the report commissioned by the Gates Foundation to analyze current vaccine manufacturing capacity in North America and Europe; (c) what were the dates of each meeting, including in person meetings and meetings conducted via teleconference, between the Public Health Agency of Canada and the Gates Foundation regarding the report commissioned by the Gates Foundation and the changes to the Canadian HIV Vaccine Initiative; and (d) on what date was the Minister or the Minister's office first informed of the report and requested changes made by the Gates Foundation concerning the Canadian HIV Vaccine Initiative?
In the House of Commons on January 31st, 2011. See this statement in context.